Regeneron says antibody injection drastically reduced Covid infection

WASHINGTON, April 13 — People who were exposed to Covid and received under-the-skin injections of Regeneron’s synthetic antibody treatment were 81 per cent less likely to develop the disease compared to those on a placebo, the company said Monday.

The trial, which was jointly run with the US National Institutes of Health, enrolled 1,505 people with household contacts who had tested positive for Covid-19.

To continue reading please click here

Leave a Reply

Related Articles

Back to top button